In the article by Esserman et al titled "Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades," there are errors in Figure 1 and in the Methods section. The boxes at the bottom of Figure 1 (CONSORT diagram) should read from left to right: "313 Received no endocrine treatment" and "339 Received tamoxifen treatment." The last line of the second paragraph of the Methods section should read "RNA was extracted, and 652 patients had 70-gene signature classification passing the quality check (Figure 1): 339 had received tamoxifen, and 313 had not received adjuvant systemic therapy." The article has been corrected online.
http://ift.tt/2eXXSXz
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου